AKBA insider trading
Akebia Therapeutics, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Buys · last 90 days
0 · $0
Most recent buy
2026-03-05
Recent insider filings
| Filed | Insider | Type | Shares | Price | Value |
|---|
| 2026-03-05 | Butler John P. CEO and President | Bought | 69,270 | $1.25 | $87k |
Most active insider buyers
| Insider | Role | Buys | Total bought |
|---|
| Butler John P. | CEO and President | 1 | $87k |
See AKBA on the chart
Every insider buy and sell for AKBA plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.
Open the browserFree sampleData from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.